2021
DOI: 10.1016/j.jep.2021.114079
|View full text |Cite
|
Sign up to set email alerts
|

Bioactivity-guided isolation of immunomodulatory compounds from the fruits of Ligustrum lucidum

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
13
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 7 publications
(13 citation statements)
references
References 52 publications
0
13
0
Order By: Relevance
“…In vitro data for HT suggest that timing is a fundamental factor in determining the final outcome of HT administration when the inflammatory stimulus is LPS. Experimental results obtained in vitro from LPS-challenged RAW264.7 macrophages demonstrated that 25 µg/mL and 12.5 µg/mL HT cotreatment for 24 h increased IL-1β release, with a mechanism that may depend on IκB-α degradation and NF-κB activation [57]. Instead, 5 µM, 10 µM, 25 µM, 50 µM, and 100 µM HT cotreatment for 6 or 18 h produced no change in IL-1β expression in the same cell line undergoing an analogous stimulation [53].…”
Section: Il-1mentioning
confidence: 93%
See 1 more Smart Citation
“…In vitro data for HT suggest that timing is a fundamental factor in determining the final outcome of HT administration when the inflammatory stimulus is LPS. Experimental results obtained in vitro from LPS-challenged RAW264.7 macrophages demonstrated that 25 µg/mL and 12.5 µg/mL HT cotreatment for 24 h increased IL-1β release, with a mechanism that may depend on IκB-α degradation and NF-κB activation [57]. Instead, 5 µM, 10 µM, 25 µM, 50 µM, and 100 µM HT cotreatment for 6 or 18 h produced no change in IL-1β expression in the same cell line undergoing an analogous stimulation [53].…”
Section: Il-1mentioning
confidence: 93%
“…Instead, in vitro data for HT revealed the activation of a pro-inflammatory molecular network when HT was not used as a pre-treatment before exposing cells to LPS. Cotreatment of LPS-stimulated mouse RAW264.7 macrophages with 50 µg/mL and 25 µg/mL caused an increase in TNF-α production flanked by a HT-dependent NF-κB activation [57], but an exposure to HT shorter than 24 h failed in producing an upregulation of TNFα [53]. A species-dependent effect may be suspected, since in mouse spleen lymphocytes, treatment with 12.5 µg/mL and 6.25 µg/mL HT was per se able to increase TNF-α production [57]; however, analogous evidence was reported for human cells, too.…”
Section: Tnf-αmentioning
confidence: 95%
“…The evidence supporting a role for OLE and HT in the regulation of immune cell frequency is minimal. Previous studies on mouse spleen lymphocytes demonstrated that 50 μg/mL HT could augment the percentage of CD3+ mouse lymphocytes, and 50, 25, 12.5, and 6.25 μg/mL HT caused an increase in the CD3+CD4−CD8− T cell subset in mouse after 48 h [ 95 ]. Moreover, 50, 100, and 200 μg/mL OLE promote the expansion of CD4+CD25+FoxP3+ T regulatory cells (Tregs) in both healthy controls and rheumatoid arthritis patients after 24 h [ 75 ].…”
Section: Discussionmentioning
confidence: 99%
“…In another in vitro model, 20–40 μM and 10–40 μM OLE reduce the LPS-triggered secretion of TNF-α and IL-6 by J774A.1 murine macrophages [ 73 ]. On the contrary, 12.5 and 6.25 μg/mL HT stimulated TNF-α secretion by mouse spleen lymphocytes [ 95 ].…”
Section: Discussionmentioning
confidence: 99%
“…Absorbance at 570 nm was measured after incubation at room temperature for 30 min. The phagocytic index was calculated using the following formula (Liu et al, 2021):…”
Section: Phagocytic Functionmentioning
confidence: 99%